Personal information

Countries

China

Activities

Collapse all

Employment (1)

Third Affiliated Hospital of Guangzhou Medical University: Guangzhou, Guangdong, CN

Chief (Gynecological oncology laboratory)
Employment
Source: Self-asserted source
Yang Zhao

Education and qualifications (2)

China Medical University: Shenyang, Liaoning, CN

Professor (Gynecology)
Qualification
Source: Self-asserted source
Yang Zhao

China Medical University: Shenyang, Liaoning, CN

2006-09-01 to 2011 | PhD. (Oncology)
Education
Source: Self-asserted source
Yang Zhao

Funding (4)

National Natural Science Foundation of China

Salary award
National Natural Science Foundation of China (Guangzhou, CN)
GRANT_NUMBER:

82072854
Source: Self-asserted source
Yang Zhao

National Natural Science Foundation of China

Salary award
National Natural Science Foundation of China (Shenyang, CN)
GRANT_NUMBER:

81772776
Source: Self-asserted source
Yang Zhao

National Natural Science Foundation of China

Salary award
National Natural Science Foundation of China (Shenyang, CN)
GRANT_NUMBER:

81472440
Source: Self-asserted source
Yang Zhao

National Natural Science Foundation of China

Salary award
National Natural Science Foundation of China (Shenyang, CN)
GRANT_NUMBER:

81202049
Source: Self-asserted source
Yang Zhao

Works (39)

Esculetin inhibits endometrial cancer proliferation and promotes apoptosis via hnRNPA1 to downregulate BCLXL and XIAP.

Cancer letters
2021-09-01 | Journal article
DOI: 10.1016/j.canlet.2021.08.039
PMID: 34480971
Source: Self-asserted source
Yang Zhao

Fusion genes in gynecologic tumors: the occurrence, molecular mechanism and prospect for therapy.

Cell death & disease
2021-08-11 | Journal article
DOI: 10.1038/s41419-021-04065-0
PMID: 34381020
PMC: PMC8357806
Source: Self-asserted source
Yang Zhao

Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression.

Cell death discovery
2021-01-22 | Journal article
DOI: 10.1038/s41420-020-00381-0
PMID: 33483472
PMC: PMC7822960
Source: Self-asserted source
Yang Zhao

CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer.

Journal of cellular and molecular medicine
2020-05-07 | Journal article
DOI: 10.1111/jcmm.15346
PMID: 32378344
PMC: PMC7299690
Source: Self-asserted source
Yang Zhao

Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway.

Journal of cellular and molecular medicine
2020-02-19 | Journal article
DOI: 10.1111/jcmm.15069
PMID: 32073729
PMC: PMC7171399
Source: Self-asserted source
Yang Zhao

CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182.

Journal of experimental & clinical cancer research : CR
2019-10-30 | Journal article
DOI: 10.1186/s13046-019-1437-z
PMID: 31666098
PMC: PMC6822369
Source: Self-asserted source
Yang Zhao

circPUM1 Promotes Tumorigenesis and Progression of Ovarian Cancer by Sponging miR-615-5p and miR-6753-5p.

Molecular therapy. Nucleic acids
2019-10-23 | Journal article
DOI: 10.1016/j.omtn.2019.09.032
PMID: 31751911
PMC: PMC6881671
Source: Self-asserted source
Yang Zhao

CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA.

Journal of cellular and molecular medicine
2019-10-22 | Journal article
DOI: 10.1111/jcmm.14736
PMID: 31639291
PMC: PMC6850961
Source: Self-asserted source
Yang Zhao

circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2019-04-11 | Journal article
DOI: 10.1016/j.biopha.2019.108832
PMID: 30965236
Source: Self-asserted source
Yang Zhao

CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2019-03-27 | Journal article
DOI: 10.1016/j.biopha.2019.108787
PMID: 30925458
Source: Self-asserted source
Yang Zhao

LncRNA TDRG1 enhances tumorigenicity in endometrial carcinoma by binding and targeting VEGF-A protein

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
2018-09 | Journal article
DOI: 10.1016/j.bbadis.2018.06.013
Part of ISSN: 0925-4439
Source: Self-asserted source
Yang Zhao
grade
Preferred source (of 2)‎

LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
2018-06-27 | Journal article
DOI: 10.1159/000490931
PMID: 29949791
Source: Self-asserted source
Yang Zhao

LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.

Journal of cellular and molecular medicine
2018-05-25 | Journal article
DOI: 10.1111/jcmm.13675
PMID: 29799152
PMC: PMC6050509
Source: Self-asserted source
Yang Zhao

lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR.

Molecular carcinogenesis
2018-05-18 | Journal article
DOI: 10.1002/mc.22835
PMID: 29745433
Source: Self-asserted source
Yang Zhao

PUM1 promotes ovarian cancer proliferation, migration and invasion.

Biochemical and biophysical research communications
2018-02-08 | Journal article
DOI: 10.1016/j.bbrc.2018.02.078
PMID: 29428722
Source: Self-asserted source
Yang Zhao

The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.

Molecular carcinogenesis
2017-11-06 | Journal article
DOI: 10.1002/mc.22749
PMID: 28984384
Source: Self-asserted source
Yang Zhao

The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.

Cell death & disease
2017-10-12 | Journal article
DOI: 10.1038/cddis.2017.486
PMID: 29022892
PMC: PMC5682654
Source: Self-asserted source
Yang Zhao
grade
Preferred source (of 2)‎

Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.

Gene
2017-09-06 | Journal article
DOI: 10.1016/j.gene.2017.09.009
PMID: 28888575
Source: Self-asserted source
Yang Zhao

Role of the lncRNA ABHD11-AS<sub>1</sub> in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC.

Molecular cancer
2017-08-17 | Journal article
DOI: 10.1186/s12943-017-0709-5
PMID: 28818073
PMC: PMC5561620
Source: Self-asserted source
Yang Zhao
grade
Preferred source (of 2)‎

DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.

Journal of cellular and molecular medicine
2017-06-09 | Journal article
DOI: 10.1111/jcmm.13217
PMID: 28598010
PMC: PMC5661118
Source: Self-asserted source
Yang Zhao

The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2017-05-01 | Journal article
DOI: 10.1177/1010428317706210
PMID: 28488543
Source: Self-asserted source
Yang Zhao

The role of miR-372 in ovarian carcinoma cell proliferation.

Gene
2017-04-27 | Journal article
DOI: 10.1016/j.gene.2017.04.043
PMID: 28456593
Source: Self-asserted source
Yang Zhao

E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.

Oncotarget
2017-02-01 | Journal article
DOI: 10.18632/oncotarget.14833
PMID: 28146423
PMC: PMC5362443
Source: Self-asserted source
Yang Zhao

The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression.

Molecular carcinogenesis
2017-01-12 | Journal article
DOI: 10.1002/mc.22599
PMID: 27991682
Source: Self-asserted source
Yang Zhao

MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.

PloS one
2016-11-09 | Journal article
DOI: 10.1371/journal.pone.0165776
PMID: 27829043
PMC: PMC5102435
Source: Self-asserted source
Yang Zhao

The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.

Oncotarget
2016-05-01 | Journal article
DOI: 10.18632/oncotarget.8485
PMID: 27050373
PMC: PMC5053670
Source: Self-asserted source
Yang Zhao

Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.

Drug design, development and therapy
2016-03-18 | Journal article
DOI: 10.2147/dddt.s102506
PMID: 27051274
PMC: PMC4807899
Source: Self-asserted source
Yang Zhao

MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.

Molecular cancer
2016-02-02 | Journal article
DOI: 10.1186/s12943-016-0496-4
PMID: 26832151
PMC: PMC4736705
Source: Self-asserted source
Yang Zhao
grade
Preferred source (of 2)‎

MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).

Oncotarget
2016-02-01 | Journal article
DOI: 10.18632/oncotarget.6544
PMID: 26673619
PMC: PMC4872740
Source: Self-asserted source
Yang Zhao

The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.

Oncotarget
2016-02-01 | Journal article
DOI: 10.18632/oncotarget.7061
PMID: 26843615
PMC: PMC4891037
Source: Self-asserted source
Yang Zhao

MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.

Journal of ovarian research
2015-12-02 | Journal article
DOI: 10.1186/s13048-015-0207-6
PMID: 26626440
PMC: PMC4667519
Source: Self-asserted source
Yang Zhao

MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.

Drug design, development and therapy
2015-09-16 | Journal article
DOI: 10.2147/dddt.s87526
PMID: 26396496
PMC: PMC4577257
Source: Self-asserted source
Yang Zhao

Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.

PloS one
2015-05-01 | Journal article
DOI: 10.1371/journal.pone.0125714
PMID: 25933027
PMC: PMC4416747
Source: Self-asserted source
Yang Zhao

RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.

Molecular cancer
2015-02-04 | Journal article
DOI: 10.1186/s12943-015-0304-6
PMID: 25649143
PMC: PMC4328068
Source: Self-asserted source
Yang Zhao

microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells.

Journal of ovarian research
2014-08-31 | Journal article
DOI: 10.1186/s13048-014-0084-4
PMID: 25297343
PMC: PMC4158041
Source: Self-asserted source
Yang Zhao

The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.

International journal of molecular sciences
2013-12-12 | Journal article
DOI: 10.3390/ijms141224187
PMID: 24351810
PMC: PMC3876104
Source: Self-asserted source
Yang Zhao

Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2013-10-17 | Journal article
DOI: 10.1007/s13277-013-1261-6
PMID: 24132590
Source: Self-asserted source
Yang Zhao

BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas.

International journal of molecular sciences
2013-09-27 | Journal article
DOI: 10.3390/ijms141019670
PMID: 24084718
PMC: PMC3821579
Source: Self-asserted source
Yang Zhao

The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.

Gynecologic oncology
2013-06-10 | Journal article
DOI: 10.1016/j.ygyno.2013.06.004
PMID: 23764197
Source: Self-asserted source
Yang Zhao

Peer review (4 reviews for 2 publications/grants)

Review activity for Cell death discovery. (1)
Review activity for Journal of experimental & clinical cancer research. (3)
How many people are using ORCID?